ロード中...
Correlation Between Bevacizumab Exposure and Survival in Patients with Metastatic Colorectal Cancer
BACKGROUND: Bevacizumab treatment is subject to large interpatient variability in efficacy, which may partly be explained by differences in complex bevacizumab pharmacokinetic characteristics that influence bevacizumab exposure. Exposure–response relationships have been identified for other monoclon...
保存先:
| 出版年: | Oncologist |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7543296/ https://ncbi.nlm.nih.gov/pubmed/32272489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0835 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|